IE
HCAT icon

Israel Englander’s Health Catalyst HCAT Stock Holding History

Israel Englander’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-454,500
Closed -$3.21M – 6075
2024
Q4 		$3.21M Buy
454,500
+124,300
+38% +$990K ﹤0.01% 3242
2024
Q3 		$2.69M Buy
+330,200
New +$2.39M ﹤0.01% 3422

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's HCAT Position: Q2 2026 in Review

Israel Englander opened a new position in Health Catalyst (HCAT) in Q2 2026: 516,083 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #4295 among its holdings. This is a return to the name: Israel Englander previously reported a position in HCAT as recently as Q4 2025.

Israel Englander first reported a position in HCAT in Q3 2019 and has held it in 25 quarters since. The position peaked at $19.1M in Q4 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Israel Englander held 516,083 shares of Health Catalyst worth $1.03M as of Q2 2026.
  • Health Catalyst was a new Israel Englander position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4295 holding.
  • Israel Englander first reported a position in Health Catalyst in Q3 2019 and has held it in 25 quarters since.
  • Israel Englander's Health Catalyst position peaked at $19.1M in Q4 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.